Final Thoughts on Advancing Hepatic Encephalopathy (HE) Management

The panel emphasizes the need for alignment and collaboration to enhance outcomes in hepatic encephalopathy (HE), stressing the importance of implementation science, APP education, and proactive screening for chronic liver disease and cirrhosis. They advocate for interdisciplinary meetings to optimize patient care and medication management, highlighting the increasing prevalence of complications related to cirrhosis in the US.

EP: 1.Epidemiology and Trends in Hepatic Encephalopathy (HE) in the United States

EP: 2.Clinical Features and Risk Factors of Hepatic Encephalopathy and Their Impact on Patient Care

EP: 3.Understanding the Differential Diagnosis and Distinctions Between Overt and Covert Hepatic Encephalopathy

EP: 4.Navigating the Clinical and Economic Landscape of Hepatic Encephalopathy (HE)

EP: 5.Optimal Strategies for Managing the Burdens Associated with Hepatic Encephalopathy (HE)

EP: 6.Optimizing Therapy Goals and Managing Overt Hepatic Encephalopathy (HE)

EP: 7.Guidelines in Action and Navigating Overt Hepatic Encephalopathy (HE) Management

EP: 8.Strategies for Addressing Precipitating Factors and Comorbidities in Hepatic Encephalopathy (HE)

EP: 9.Optimizing Continuity of Care to Enhance Patient Outcomes and Reduce Hospitalizations in Hepatic Encephalopathy (HE)

EP: 10.Coordinated Care Strategies and Enhancing Patient Outcomes in Hepatic Encephalopathy (HE)

EP: 11.Navigating Insurance Challenges and Transitions of Care in Hepatic Encephalopathy (HE)

EP: 12.Diagnosis of hepatic encephalopathy (HE) with a Case Study

EP: 13.Collaborating with Payers to Improve Outcomes in HE

Now Viewing

EP: 14.Final Thoughts on Advancing Hepatic Encephalopathy (HE) Management

---

This series was supported by Salix Pharmaceuticals.

Related Videos